⌘K
t
BioPharma Credit PLC will announce its audited Full Year Results for the period ending 31 December 2025 on Tuesday 24 March 2026. A management presentation will be delivered at 14:00 GMT via a webcast facility on the same day.
| Date | 3 Feb 2026 |
| Time | 07:00:10 |
| Category | Results |
| ID | 4029R |
BioPharma Credit PLC
3 February 2026
BIOPHARMA CREDIT PLC
(the "Company")
NOTICE OF FULL YEAR RESULTS
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, will announce its audited Full Year Results for the period ending 31 December 2025 on Tuesday 24 March 2026.
A management presentation will be delivered at 14.00 GMT through a webcast facility. To register to attend or request details, RSVP to biopharmacredit@buchanan.uk.com.
-Ends-
Enquiries:
BioPharma Credit plc
via MUFG Corporate Governance Limited
Company Secretary
+44 (0) 333 300 1932
Burson Buchanan
Mark Court / Jamie Hooper / Henry Wilson / Nick Croysdill
+44 (0) 20 7466 5000
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24